Table 1.
Baseline Clinical and Demographic Characteristics of IOP-Controlled and IOP-Lowering Glaucoma Participants Included in the Study
| Control Group (n = 39) | Treatment Group (n = 47) | P | |
|---|---|---|---|
| Age (y), mean ± SD | 68 ± 9 | 65 ± 13 | 0.2 |
| Female/male (n) | 14/25 | 17/30 | 1.00 |
| Glaucoma subtype (n) | |||
| Glaucoma suspect | 12 | 10 | 0.3 |
| POAG | 24 | 29 | 0.3 |
| PACG | 1 | 1 | 0.8 |
| PXFG | 2 | 4 | 0.5 |
| PDG | 0 | 3 | NA |
| Baseline IOP (mm Hg), mean ± SD | 14 ± 3 | 22 ± 7 | < 0.0001 |
| Central cornea thickness (µm), mean ± SD | 532 ± 34 | 540 ± 35 | 0.3 |
| Baseline mean deviation (dB), mean ± SD | –4.6 ± 4.2 | –5.0 ± 5.0 | 0.7 |
| Baseline RNFLT (µm), mean ± SD | 72 ± 18 | 70 ± 17 | 0.6 |
| Mean follow-up duration (mo), mean ± SD | 3.9 ± 0.8 | 3.4 ± 1.1 | 0.02 |
Unpaired Student's t-test and χ2 test for proportions were performed; where proportions were 0, the χ2 test could not be performed. POAG, primary open-angle glaucoma; PACG, primary angle-closure glaucoma; PXFG, pseudo-exfoliation glaucoma; PDG, pigment dispersion glaucoma; NA, not available.